Pavel Mirovsky
2012
In 2012, Pavel Mirovsky earned a total compensation of $1.7M as President and General Manager, Europe at Valeant Pharmaceuticals International.
Compensation breakdown
| Non-Equity Incentive Plan | $222,584 |
|---|---|
| Option Awards | $382,000 |
| Salary | $414,514 |
| Stock Awards | $652,060 |
| Other | $21,331 |
| Total | $1,692,489 |
Mirovsky received $652.1K in stock awards, accounting for 39% of the total pay in 2012.
Mirovsky also received $222.6K in non-equity incentive plan, $382K in option awards, $414.5K in salary and $21.3K in other compensation.
Rankings
In 2012, Pavel Mirovsky's compensation ranked 4,120th out of 11,487 executives tracked by ExecPay. In other words, Mirovsky earned more than 64.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,120 out of 11,487 | 64th |
Division Manufacturing | 1,426 out of 4,253 | 67th |
Major group Chemicals And Allied Products | 322 out of 1,198 | 73rd |
Industry group Drugs | 194 out of 920 | 79th |
Industry Pharmaceutical Preparations | 148 out of 700 | 79th |
Source: SEC filing on April 9, 2015.
Mirovsky's colleagues
We found three more compensation records of executives who worked with Pavel Mirovsky at Valeant Pharmaceuticals International in 2012.